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Eag1  K+ channels  blockade  in  the  dentate  gyrus  of  the  hippocampus  did  not  modify  apomorphine-disruptive  effects  in the PPI.
Dentate  gyrus  surgery  inducing  decreased  startle  response  was restored  by the  Eag1  antibody.
The  role  of  Eag1  K+ channels  in  the  startle  response  merits  further  investigation.
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a  b  s  t  r  a  c  t
Recently,  our  group  described  the  ether-à-go-go1(Eag1) voltage-gated  potassium  (K+)  channel  (Kv10.1)
expression  in  the dopaminergic  cells  indicating  that  these  channels  are  part  of the  diversiﬁed  group  of ion
channels  related  to  dopaminergic  neurons  function.  The  increase  of dopamine  neurotransmission  induces
a  reduction  in the  prepulse  inhibition  (PPI)  of the  acoustic  startle  reﬂex  in  rodents,  which  is a reliable
index  of  sensorimotor  gating  deﬁcits.  The  PPI response  has been reported  to  be  abnormally  reduced  in
schizophrenia  patients.  The  role  of  Eag1  K+ channels  in the PPI  reaction  had  not been revealed  until now,
albeit  the  singular  distribution  of  Eag1  in  the  dentate  gyrus  of  the hippocampus  and  the  hippocampal
regulation  of the startle  reﬂex  and PPI.  The  aim  of  this  work  was  to  investigate  if Eag1  blockade  onchizophrenia
ag1
v10.1
tartle reﬂex
hippocampus  modiﬁes  the  PPI-disruptive  effects  of  apomorphine  in  Wistar  rats.  Bilateral  injection  of
anti-Eag1  single-chain  antibody  into  the  dentate  gyrus  of  hippocampus  did not  modify  apomorphine-
disruptive  effects  in the PPI  response.  However,  Eag1  antibody  completely  restored  the  startle  amplitude
decrease  revealed  after dentate  gyrus  surgery.  These  potentially  biological  important  phenomenon  merits
further investigation  regarding  the  role of Eag1  K+ channels,  mainly,  on  startle  reﬂex modulation,  since
the  physiological  role  of  these  channels  remain  obscure.. Introduction
Ether-à-go-go-related gene (ERG) potassium (K+) channel is
ainly expressed in the human and rodents adult brain [23,24].
RG K+ channels belong to a superfamily of voltage-activated K+
hannels encoded by three distinct gene subfamilies, including
ther-à-go-go (eag), ether-à-go-go-like (elk), and ether-à-go-go-
elated (erg) genes [8,42]. Among them, the Eag K+ channel appears
o be the only mainly neuron-speciﬁc and localized to synapses
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[18]. Eag K+ channel is represented by the Eag1 gene (KCNH1,
Kv10.1) [26,42] and Eag2 (KCNH5, Kv10.2) [19,23]. Highest Eag1
gene expression is found in the cerebral cortex, hippocampus, cere-
bellum and hypothalamus of human and rat, which greatly overlaps
with Eag1 protein expression [24]. However, the function of Eag1
K+ channels in the central nervous system is still unknown [26,27].
It was  suggested that the lateral diffusion of Eag1 ion channels acts
as a dynamical mechanism to accrue these channels to the synap-
tic terminals, where they should play a pivotal role for synaptic
function and plasticity [11]. The expression of the Eag1 K+ channel
is high in the nigrostriatal pathway and it is co-localized with the
dopaminergic cells [7]. This data suggests that these channels may
well participate in the physiology of the dopaminergic system [7].Sensorimotor gating is the ability to gate out irrelevant stimuli,
a normal central inhibitory processes expression, and its ability can
be accessed through prepulse inhibition (PPI) in humans [2,29,38]
and rodents [3,36,37]. Schizophrenia patients exhibit heritable
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eﬁcits in the PPI response [2], and generally, in rodents, PPI deﬁcit
s pharmacologically induced through an increase of dopaminergic
eurotransmission [3,36,43]. The dopaminergic (D1/D2) receptor
gonist apomorphine induces a reduction in the PPI response of
he acoustic startle reﬂex in rodents, which is a reliable index of
he sensorimotor gating deﬁcit [35]. The ability of antipsychotics
rugs to restore the PPI disruption may  be predictive of its antipsy-
hotic effects [9]. Dopaminergic dysfunction remains the central
athophysiological theory of schizophrenia (for review see [15]),
owever, the schizophrenia physiopathology might also be related
o a brain development and plasticity disorder. In this case, the
ctivity and excitability of multiple brain regions including hip-
ocampus and substantia nigra, may  be strongly altered [33,34].
Evidence for the hippocampal involvement in the neuropath-
logy of schizophrenia has been found in humans, from in vivo
europsychology, structural and functional imaging, and also from
ost mortem histological, morphometric and genetic analyses [14].
peciﬁc evidence for the hippocampal regulation of PPI comes from
xperimental animal studies [5,39]. Recently, K+ channels have
een proposed to play a role in the mechanisms of neural plasticity
hich are altered in various psychiatric disorders, especially in hip-
ocampus [16]. The dentate gyrus of the hippocampus acts as the
gate keeper” or the “ﬁlter” of the hippocampal function [10]. It has
een described that dopamine modulates the activity of new den-
ate granule cells in the dentate gyrus [25]. Also, dopamine acts as
 gate on the direct cortical input to the hippocampus, modulating
ynaptic plasticity and information ﬂow in a frequency-dependent
anner [17]. In this context, Eag1 K+ channel expression in the
entate gyrus of hippocampal neurons [7] becomes interesting.
Because of the lack of speciﬁc pharmacological instruments,
ag1 monoclonal antibody may  provide an attractive tool to elu-
idate the functional role of this channel in mammalian brain
24]. Monoclonal antibodies represent a strategy to generate highly
elective inhibitors against cell surface molecules, enabling a spe-
iﬁc antigen to be distinguished from its close homologues [12,31].
 speciﬁc Eag1 antibody was validated and described as the ﬁrst
onoclonal antibody that selectively inhibits a K+ current in intact
ells [12]. Taking advantage of the speciﬁcity of the recombinant
nti-Eag1 single-chain antibody, and the singular distribution of
ag1 in the hippocampus (Fig. 1) [7] we investigate the effects of
ag1 antibody microinjection into the dentate gyrus of rats after
ystemic apomorphine treatment.
. Materials and methods
.1. Animals
Male Wistar rats (n = 11; 250–300 g) were used. The experi-
ental protocol followed the guidelines for the care and use of
ammals in Neuroscience and Behavioral Research (ILAR, USA).
ats were housed four per cage, under controlled temperature
23 ± 1 ◦C) and light/dark cycle (12–12 h; lights on at 0600 hours)
ith food and water constantly available. Tests were performed in
he light phase.
.2. Drugs
Apomorphine (Sigma–Aldrich, Germany) was dissolved in dis-
illed water with 0.1% ascorbic acid and injected subcutaneously
s.c.; 0.5 mg/kg) at 1 ml/kg. Eag1-speciﬁc recombinant anti-Eag1
ingle-chain antibody (1 g/1 l of water RNAse free) was  bilat-
rally injected with 30 gauge needles (16 mm)  into the dentate
yrus at a volume of 0.5 L delivered over 60 s using a microdrive
njection pump.etters 559 (2014) 13– 17
2.3. Sensorimotor evaluation
PPI refers to the reduction in the startle magnitude to a startling
acoustic stimulus ‘pulse’ when it is shortly preceded by a weaker
‘prepulse’ stimulus [35]. Startle response and PPI were conducted
simultaneously in two  identical startle systems (Med Associates,
Inc., USA) as described before [30].
2.3.1. Pre-test procedure
Rats were subjected to a PPI pre-test session previously to the
surgery. All animals selected to conduct the study presented a pos-
itive response to the PPI and an average of startle amplitude of
589 ± 107 (arbitrary units).
2.3.2. Post-surgical test procedure
One week after surgery, animals were re-subjected to the PPI
test (post-surgical analyses) before apomorphine treatment.
2.4. Surgery
Rats were anesthetized with ketamine/xylazine (10:7,
100 mg/kg; intraperitoneal) and placed in a stereotaxic appa-
ratus. Stainless steel guide cannulae were bilaterally implanted
3 mm above the injection site within the dentate gyrus (antero-
posterior, −4 mm;  lateral, ±2.6 mm;  dorso-ventral, −2.1 mm)  [28].
The guide cannulae were kept unobstructed by dummy stylets.
2.5. Experimental design
After surgery for bilaterally hippocampus cannulae implanta-
tion all rats showed a signiﬁcant decrease of their startle amplitude
(compared to pre-test condition). Animals were tested repeatedly
(pre-test, post-surgical apomorphine, and apomorphine + Eag1 K+
channel antibody) with a minimum interval of 4 days, with excep-
tion of the post surgical test. PPI disruption was induced by acute
apomorphine treatment. Microinjection of the anti-Eag1 K+ chan-
nel antibody bilaterally in the dentate gyrus of hippocampus was
conducted 20 min  after the apomorphine treatment. Two rats were
not included in the behavioral analyses (Fig. 2).
2.6. Statistical analyses
The acoustic startle response to pulse alone and to pre-
pulse + pulse was analyzed by repeated measures analysis of
variance (RM-ANOVA) with stimuli (four levels: pulse; 81 or 73
or 69 dB prepulse + pulse) as a within-subjects factor and condition
(pre or post-surgical or pharmacological treatment; four levels) as
between-subjects factors. For the mean %PPI, RM-ANOVA was con-
ducted with intensity of prepulse (three levels) as a within-subject
factor, and condition as a between-subjects factor. In the case of
signiﬁcant main effects the RM-ANOVA was  followed by Duncan’s
test for post hoc comparisons (P < 0.05).
3. Results
3.1. Startle amplitude
We  found a signiﬁcant main effect of stimuli (F(3,96) = 13.017;
P = 0.000) and condition (F(3,32) = 6.48; P = 0.001), but not a signif-
icant interaction between stimuli and condition (F(9,96) = 1.866;
P = 0.066). Rats with bilateral cannulae implantation into the den-
tate gyrus showed a signiﬁcant decrease in their startle amplitude
to the pulse alone compared with the pre-test condition (Fig. 3).
Apomorphine systemic treatment induced an increase in the startle
amplitude, but this effect was  not statistically signiﬁcant. After Eag1
antibody bilaterally injected into the dentate gyrus of hippocampus
A.C. Issy et al. / Neuroscience Letters 559 (2014) 13– 17 15
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cig. 1. Photomicrographs A and B showing Eag1 immunoreactivity in the rat hippo
ell  bodies.
he startle amplitude was signiﬁcantly increased (bring to nor-
al) compared with the post-surgical condition (post hoc Duncan;
 < 0.05; Fig. 3). In the 81 and 73 dB prepulse + pulse trials the startle
agnitude was signiﬁcant lower than the respective stimulus of
he pre-test condition. However, importantly, the startle ampli-
ude to the pulse was higher than the startle amplitude to the
repulse + pulse (with all prepulse intensities) in the post surgical
ondition (Fig. 3).
.2. Prepulse inhibitionThere was  a signiﬁcant effect of condition (F(3,32) = 4.10;
 = 0.014), but not of prepulse intensity (F(2,64) = 0.185; P = 0.831)
r an interaction between prepulse intensity and condition
ig. 2. Hematoxilin-eosin representative histological section and cannulae-tip
lacements schema within the dentate gyrus of hippocampus. Injection needle tips
ocation within the dentate gyrus of hippocampus was determined according to the
tandardized plates – Bregma −2.06; interaural 1.74 mm  [28]. Two  animals within
annulae insertions outside the dentate gyrus were not included in data analyses.us. The detection system (NBT/BCIP) produced an intense blue color mainly in the
(F(6,64) = 1.105; P = 0.369). Systemic treatment with apomorphine
induced signiﬁcant PPI disruption. Eag1 antibody injected bilat-
erally into the dentate gyrus did not modify this effect (post hoc
Duncan; P < 0.05; Fig. 4). PPI on post-surgical condition was  not
different to the pre-test (data not shown).
4. Discussion
Dopamine system appears to be critical connected to the PPI
modulation [36]. PPI response may  be disrupted in schizophrenia
patients [2,36], despite the fact that PPI impairment is observed in
several other psychiatric disorders [2,9]. Clearly, the PPI deﬁcit that
is experimentally induced does not constitute an animal model of
schizophrenia per se but appears to provide an applicable model of
sensorimotor gating deﬁcit [9,25]. The antipsychotic drugs used to
treat schizophrenia symptoms share the pharmacological property
of dopamine D2 receptor antagonism [20]. It was suggested, how-
ever, that the therapeutic action of antipsychotic drugs could be in
addition dependent on the presynaptic ERG K+ channel inhibition
[6,32,40]. We  investigate the ability of an Eag1 K+ channel antibody
microinjected into the dentate gyrus of hippocampus to attenu-
ate the apomorphine-induced PPI disruption. Bilateral injection of
Fig. 3. Effects of Eag1 K+ channels antibody on the startle amplitude. Animals
showed signiﬁcant decrease in their startle amplitude to pulse alone after surgery.
Apomorphine treatment induced an increase in the startle response, but this effect
was  not statistically signiﬁcant. The Eag1 K+ channels antibody bilaterally injected in
the  dentate gyrus of hippocampus restored the startle amplitude. *P < 0.05 compared
with the respective stimulus of the pre-test condition. Data represent means ± SEM.
RM-ANOVA, post hoc Duncan (P < 0.05; n = 9).
16 A.C. Issy et al. / Neuroscience L
Fig. 4. Effects of Eag1 K+ channels antibody in the PPI disruption induced by
apomorphine. Eag1 K+ channels antibody bilaterally injected on dentate gyrus of
hippocampus did not modify the PPI-disruptive effect of apomorphine (prepulse
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dots, PLoS One 5 (2010) e8858.ntensities of 73 and 81 dB). *P < 0.05 compared with post-surgical condition. Data
epresent means ± SEM. RM-ANOVA, post hoc Duncan (P < 0.05; n = 9).
ag1 antibody (0.5 g data not shown; or 1.0 g) into the dentate
yrus did not modify apomorphine-disruptive effects in the PPI, but
eversed the decreased startle amplitude measured after surgery.
No physiological function for the Eag1 K+ channels in the central
ervous system has been reported so far for mammals. Recently,
o difference in the PPI disruption induced by apomorphine in
ag1 knockout animals was found, corroborating with our results
41]. However, these authors demonstrate that Eag1 knockout
ice (Kv10.1−/−) show an increased reactivity to apomorphine
reatment in the PPI test after amphetamine sensitization, and a
igniﬁcant increase in the responsiveness to the haloperidol in the
atalepsy test. The authors suggested that Kv10.1−/− mice show a
yperreactivity of the dopaminergic system, or a decreased den-
ity/number of the dopaminergic receptors [41].
It was impossible to disclose the reason for decreasing startle
mplitude after the hippocampal cannulae implantation. Despite
he fact that startle reﬂex is sensitive to habituation, and may
eﬂect hearing loss, these do not appear the reasons for the
tartle decrease. Zhang and co-workers conducted several studies
sing an extensive number of drug-free rats with dorsal or ven-
ral hippocampal-cannulation [1,44–46], but these authors did not
escribe any startle reﬂex impairment. Contrasting, it has been
eported the impact of different manipulations on ventral or dor-
al hippocampus in the startle reactivity [45,46]. In addition, Zhang
nd co-workers [46] suggested that these effects in the startle reac-
ivity may  be mediated through the hippocampal projections to
he amygdala or to the bed nucleus of the stria terminalis, which
ave access to the brain stem startle circuit [21]. Primary acous-
ic startle pathway involves few synapses including the cochlear
oot neurons, neurons in the nucleus reticularis pontis caudalis, and
otoneurons in the spinal cord [22]. Since the startle reﬂex is high
ensitive to habituation, sensitization, sensorimotor gating, and
ffective modulation, it might be used to study several conditions
ncluding fear and anxiety, affective disturbances, motivational
tates, and homeostasis [13]. Undoubtedly, Eag1 K+ channel block-
de effects in the startle response merits further investigation.
Contrasting, consistent with Swerdlow and co-workers [35] we
hould carefully interpreting treatment effects in the PPI response
n the presence of parallel effects on startle amplitude. Consis-
ent with these authors it is possible that in the presence of a
eduction in the startle magnitude in pulse-alone trials it is dif-
cult to determine whether the lack of a comparable reduction
[etters 559 (2014) 13– 17
in startle magnitude in prepulse + pulse trials reﬂects a reduction
in sensorimotor gating, or a ‘ﬂoor’ effect in the prepulse + pulse
trials. In the same way, an increase in startle magnitude of both
pulse-alone trials and prepulse + pulse trials could reﬂects ‘ceiling’
effects, rather than a reduction in sensorimotor gating. However,
despite the effects of surgical procedure in the startle amplitude,
our data demonstrate the ability of apomorphine to reduce PPI, as
described before, even in the presence of apomorphine effects in
startle amplitude [4,35]. If the absence of Eag1 blockade effects in
the PPI response was  inﬂuenced by its effects in the startle ampli-
tude is not possible to determine via these data alone.
5. Conclusion
Eag1 K+ channels blockade modiﬁed the startle response with-
out robustly affecting the apomorphine-disruptive effects in the
PPI. We  provide the ﬁrst demonstration of the possible inﬂuence
of these channels in the startle response, which may  represent a
biological important phenomenon. Although our results do not sup-
port the classical antipsychotic-like effects to the Eag1 K+ channels
blockade data merits further studies.
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